MRI characteristics in focal hepatic disease before and after administration of MnDPDP: Discriminant analysis as a diagnostic tool

European Radiology

Volumn 12, Issue 1, 2002, Pages 62-70

  Helmberger, Thomas K ^a   Laubenberger, Jörg ^b   Rummeny, Ernst ^c   Jung, Gregor ^d   Sievers, Klaus ^e   Döhring, Wilfried ^f   Meurer, Karoline ^g   Reiser, Maximilian F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e Radiology Associates Dortmund   (Germany)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

^g Nycomed Amersham   (Germany)

Author keywords

Abdomen; Comparative studies; Contrast media; Liver; Magnetic resonance

Indexed keywords

MANGAFODIPIR; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDETIC ACID; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; DOSE RESPONSE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CYST; LIVER DISEASE; LIVER HEMANGIOMA; LIVER INJURY; LIVER METASTASIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NAUSEA; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STANDARD; STATISTICAL MODEL; ADOLESCENT; ADULT; AGED; BREAST TUMOR; COLORECTAL TUMOR; FEMALE; HEMANGIOMA; LIVER; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STATISTICS;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DISCRIMINANT ANALYSIS; EDETIC ACID; FEMALE; HEMANGIOMA; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PYRIDOXAL PHOSPHATE; SENSITIVITY AND SPECIFICITY;

EID: 0036365956     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300101122     Document Type: Article

References (22)

1. Low RN (1998) Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver. Top Magn Reson Imaging 9:141-166
2. Semelka RC, Schlund JF, Molina PL, Willms AB, Kahlenberg M, Mauro MA, Weeks SM, Cance WG (1996) Malignant liver lesions: comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging 1:39-43
3. Seneterre E, Taourel P, Bouvier Y, Pradel J, Van Beers B, Daures JP, Pringot J, Mathieu D, Bruel JM (1996) Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785-792
4. Semelka RC, Lee JK, Worawattanakul S, Noone TC, Patt RH, Ascher SM (1998) Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI. J Magn Reson Imaging 8:670-674
5. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ (1999) Hepatic lesion detection: comparison of MR imaging after administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210:459-466
6. Rummeny EJ, Torres CG, Kurdziel JC, Nilsen G, Op de Beek B, Lundby B (1997) MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Acta Radiol 38:638-642
7. Bernardino ME, Young SW, Lee JK, Weinreb JC (1992) Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology 183:53-58
8. Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME (1993) Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 188:53-59
9. Birnbaum BA, Weinreb JC, Fernandez MP, Brown JJ, Rofsky NM, Young SW (1994) Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings. Clin Imaging 18:21-27
10. Leander P (1995) Liver-specific contrast media for MRI and CT experimental studies. Acta Radiol (Suppl) 396:1-36
11. Murakami T, Baron RL, Peterson MS, Oliver JH III, Davis PL, Confer SR, Federle MP (1996) Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 200:69-77
12. Rofsky NM, Earls JP (1996) Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging. Magn Reson Imaging 4:73-85
13. Kellar KE, Briley-Saebo K (1998) Phantom standards with temperature-and field-independent relaxation rates for magnetic resonance imaging. Invest Radiol 33:472-479
14. Kendall M, Stuart A, Ord JK (1983) The advanced theory of statistics, vol 3, 4th edn. Griffin, London
15. Bernardino ME, Young SW, Lee JK, Weinreb J (1991) Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease. Invest Radiol 26:S150-155
16. Hamm B, Vogl TJ, Branding G, Schnell B, Taupitz M, Wolf KJ, Lissner J (1992) Focal liver lesions: MR im aging with Mn-DPDP - initial clinical results in 40 patients. Radiology 182:167-174
17. Rofsky NM, Weinreb JC (1992) Manganese (II) N,N′-dipyridoxylethyl-enediamine-N,N′-diacetate 5,5′-bis(phosphate): clinical experience with a new contrast agent. Magn Reson Q 8:156-168
18. Liou J, Lee JKT, Borrello AJ, Brown JJ (1994) Differentiation of hepatomas from nonhepatomatous masses. Use of MnDPDP-enhanced MR images. Magn Reson Imaging 12:71-76
19. Coffin CM, Diche T, Mahfouz A, Alexandre M, Caseiro-Alves F, Rahmouni A, Vasile N, Mathieu D (1999) Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 9:444-449
20. Helmberger T, Gregor M, Holzknecht N, Gauger J, Rau H, Reiser MF (1999) Comparison of dual-phase helical CT with native and ferum oxide-enhanced magnetic resonance imaging in detection and characterization of focal liver lesions. Radiologe 39:678-684
21. Pawluk RS, Tummala S, Brown JJ, Borello JA (1999) A retrospective analysis of the accuracy of T2-weighted images and dynamic gadolinium-enhanced sequences in the detection and characterization of focal heaptic lesions. J Magn Reson Imaging 9:266-273
22. Oudkerk M, Heuser LJ, Heller M, Van Dijk P, Brouwers EM, Song B (1999) Better liver lesion diagnosis with Mangafodipir Trisodium (MnDPDP)-enhanced MR liver imaging: a multicenter study comparing MR and biphasic CT. Radiology 213(P):338